PRESIDENT & CHIEF SCIENTIFIC OFFICER - Joslin Diabetes Center

PRESIDENT & CHIEF SCIENTIFIC OFFICER Joslin Diabetes Center The Beth Israel Lahey Health (BILH), Joslin Diabetes Center is seeking applications and nominations for the position of President and Chief Scientific Officer. An academic appointment as Full or Associate Professor in the Field of Diabetes at Harvard Medical School (HMS) will be commensurate with experience, training, and achievements in addition to teaching activities. Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. As one of only 18 NIH-designated Diabetes Research Center in the United States serving more than 20,000 adults and children each year, Joslin sets the standard for diabetes treatment by providing highly specialized care and education. Its clinical models are recognized as the standard care for treating diabetes and related complications in both the United States and around the world. The center’s team of diabetes educators, including nurses, dieticians and exercise physiologists, are nationally certified by the American Diabetes Association, ensuring the highest quality of care and education for patients. The President & Chief Scientific Officer will serve as a visionary leader responsible for defining and advancing the scientific and strategic direction of Joslin Diabetes Center. This individual will oversee all core departments, including Research, Clinical Services, Fiscal Services, Philanthropy, Commercial Ventures and Quality, ensuring integration with BILH while maintaining Joslin’s identity as an independent center of excellence. In close collaboration with BILH leadership, the Joslin Board of Trustees and Harvard Medical School, the President & Chief Scientific Officer will align research, clinical and educational missions to drive innovation, sustainability, and impact in diabetes care and discovery. Responsibilities Oversee all core departments, including Research, Clinical Services, Fiscal Services, Philanthropy, Commercial Ventures and Quality. Work closely with BILH leadership, the Joslin Board of Trustees, and Harvard Medical School to align research, clinical and educational missions. Drive innovation, sustainability, and impact in diabetes care and discovery. Qualifications Nationally or internationally recognized leaders in academic medicine or diabetes research with a proven track record of scientific achievement, programmatic leadership, and team development. Demonstrated vision for advancing academic accomplishment and leadership skills to nurture research, teaching, and clinical portfolios of an outstanding Field of Diabetes. Exemplary administrative, operational, financial, academic mentoring, and communication acumen. Ability to inspire collaboration, drive innovation, and advance Joslin’s global reputation as a pioneer in diabetes treatment and research. Prospective applicants should apply directly to the Workday posting. For any questions, please direct them to Committee Chair: Mark Zeidel, MD, Chair, Department of Medicine and Physician in Chief, BIDMC, Herrman L. Blumgart Professor of Medicine, HMS, mzeidel@bidmc.harvard.edu. Link to apply. The pay range listed for this position is $350,000-$540,000, which is the annual base salary range the organization reasonably and in good faith expects to pay for this position at this time. In addition to base compensation, this position may be eligible for additional compensation, which may include performance-based incentive bonuses. We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, gender identity, sexual orientation, pregnancy and pregnancy-related conditions or any other characteristic protected by law. #J-18808-Ljbffr